Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 21: | Line 21: | ||
:::* Preferred regimen in level three evidence: [[doxycycline]] as an alternative to [[macrolide]] {{or}} [[fluoroquinolone]] for [[penicillin allergic patients]] | :::* Preferred regimen in level three evidence: [[doxycycline]] as an alternative to [[macrolide]] {{or}} [[fluoroquinolone]] for [[penicillin allergic patients]] | ||
:::* Preferred regimen in Penicillin allergic patients: [[Fluoroquinolone]] {{and}} [[aztreonam]] | :::* Preferred regimen in Penicillin allergic patients: [[Fluoroquinolone]] {{and}} [[aztreonam]] | ||
:::* Preferred regimen for | :::* Preferred regimen for Community acquired methicillin resistant staphylococcus aureus infection: [[vancomycin]] {{or}} [[linezolid]] | ||
::* 3. '''Inpatient Intensive care unit treatment''' | |||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Revision as of 15:21, 15 July 2015
- Mycoplasma pneumoniae
Return to Top
-
- 1. Community-acquired pneumonia
- Preferred regimen: Macrolide OR Tetracycline
- Alternative regimen: Fluoroquinolone
- 2. Outpatient treatment
- 2.1 Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection:
- Preferred regimen:Macrolides (azithromycin, clarithromycin, OR erythromycin) (strong recommendation)
- Alternative regimen: Doxycycline
- 2.2 Preferred regimen in presence of comorbidities, such as chronic heart, lung, liver, or renal disease; diabetes mellitus; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; use of antimicrobials within the previous 3 months or other risks for drug resistant Streptococcus pneumoniae infection: Option A Fluoroquinolone (moxifloxacin, gemifloxacin, OR levofloxacin Option B beta-lactam AND a macrolide
- 2.3 Preferred regimen in regions with a high rate of infection macrolide resistant S. pneumoniae: Fluoroquinolone (moxifloxacin, gemifloxacin, OR levofloxacin and beta-lactam AND a macrolide
- 3. Inpatient non Intensive care unit treatment
- Preferred regimen:fluoroquinolone
- Preferred regimen in level one evidence: beta-lactam AND macrolide(Preferred beta-lactam agents include cefotaxime, ceftriaxone, and ampicillin; ertapenem for selected patients
- Preferred regimen in level two evidence: beta-lactam (cefotaxime, ceftriaxone OR ampicillin-sulbactam) AND either azithromycin OR fluoroquinolone
- Preferred regimen in level three evidence: doxycycline as an alternative to macrolide OR fluoroquinolone for penicillin allergic patients
- Preferred regimen in Penicillin allergic patients: Fluoroquinolone AND aztreonam
- Preferred regimen for Community acquired methicillin resistant staphylococcus aureus infection: vancomycin OR linezolid
- 3. Inpatient Intensive care unit treatment
References
- ↑ Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC; et al. (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clin Infect Dis. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083.
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.